ArticleAmerican journal of cancer research2024

The small-molecule drug homoharringtonine targets HSF1 to suppress pancreatic cancer progression.

Gui-Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.